142 related articles for article (PubMed ID: 25373850)
1. Role of metalloproteinases in tendon pathophysiology.
Sbardella D; Tundo GR; Fasciglione GF; Gioia M; Bisicchia S; Gasbarra E; Ippolito E; Tarantino U; Coletta M; Marini S
Mini Rev Med Chem; 2014; 14(12):978-87. PubMed ID: 25373850
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinases: How Much Can They Do?
Ågren MS; Auf dem Keller U
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
[TBL] [Abstract][Full Text] [Related]
4. Extracellular regulation of metalloproteinases.
Yamamoto K; Murphy G; Troeberg L
Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
[TBL] [Abstract][Full Text] [Related]
5. MMPs and ADAMTSs in intervertebral disc degeneration.
Wang WJ; Yu XH; Wang C; Yang W; He WS; Zhang SJ; Yan YG; Zhang J
Clin Chim Acta; 2015 Aug; 448():238-46. PubMed ID: 26162271
[TBL] [Abstract][Full Text] [Related]
6. MMPs and ADAMTSs: functional studies.
Flannery CR
Front Biosci; 2006 Jan; 11():544-69. PubMed ID: 16146752
[TBL] [Abstract][Full Text] [Related]
7. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cells do not decrease the ultimate tensile strength of intact tendons in vivo and in vitro: protective role of mechanical loading.
Marsolais D; Duchesne E; Côté CH; Frenette J
J Appl Physiol (1985); 2007 Jan; 102(1):11-7. PubMed ID: 16916923
[TBL] [Abstract][Full Text] [Related]
10. Tendinopathy--from basic science to treatment.
Riley G
Nat Clin Pract Rheumatol; 2008 Feb; 4(2):82-9. PubMed ID: 18235537
[TBL] [Abstract][Full Text] [Related]
11. The "other" 15-40%: The Role of Non-Collagenous Extracellular Matrix Proteins and Minor Collagens in Tendon.
Taye N; Karoulias SZ; Hubmacher D
J Orthop Res; 2020 Jan; 38(1):23-35. PubMed ID: 31410892
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
13. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
[TBL] [Abstract][Full Text] [Related]
14. Molecular events in tendinopathy: a role for metalloproteases.
Magra M; Maffulli N
Foot Ankle Clin; 2005 Jun; 10(2):267-77. PubMed ID: 15922918
[TBL] [Abstract][Full Text] [Related]
15. Extracellular metalloproteinases in neural crest development and craniofacial morphogenesis.
Christian L; Bahudhanapati H; Wei S
Crit Rev Biochem Mol Biol; 2013; 48(6):544-60. PubMed ID: 24066766
[TBL] [Abstract][Full Text] [Related]
16. Development of tendon structure and function: regulation of collagen fibrillogenesis.
Zhang G; Young BB; Ezura Y; Favata M; Soslowsky LJ; Chakravarti S; Birk DE
J Musculoskelet Neuronal Interact; 2005 Mar; 5(1):5-21. PubMed ID: 15788867
[TBL] [Abstract][Full Text] [Related]
17. Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.
Theocharis AD; Gialeli C; Bouris P; Giannopoulou E; Skandalis SS; Aletras AJ; Iozzo RV; Karamanos NK
FEBS J; 2014 Nov; 281(22):5023-42. PubMed ID: 25333340
[TBL] [Abstract][Full Text] [Related]
18. Matrix metabolism rate differs in functionally distinct tendons.
Birch HL; Worboys S; Eissa S; Jackson B; Strassburg S; Clegg PD
Matrix Biol; 2008 Apr; 27(3):182-9. PubMed ID: 18032005
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon.
Södersten F; Ekman S; Eloranta ML; Heinegård D; Dudhia J; Hultenby K
Matrix Biol; 2005 Aug; 24(5):376-85. PubMed ID: 16005620
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
Georgiadis D; Yiotakis A
Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
